Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Tosufloxacin tosilate eye drops submitted for Japanese approval

June 9, 2004

No Comments

SnET2 NDA accepted for priority review

June 4, 2004

No Comments

Proposed financing at InSite to advance AzaSite development

June 4, 2004

No Comments

Allergan and Kyorin sign Japanese agreement for Alphagan franchise

June 2, 2004

No Comments

FDA sets date to discuss Macugen NDA

June 1, 2004

No Comments

Allergan presents new prostaglandin analogues with utility as ocular hypotensive agents

May 28, 2004

No Comments

NDA filing for Xibrom

May 27, 2004

No Comments

Allergan and Senju sign Japanese licensing agreement for Lumigan

May 27, 2004

No Comments

Novel ocular hypotensive agent BVT-28949 effective in monkeys

May 20, 2004

No Comments

Pharmacokinetics and efficacy of ranibizumab in exudative AMD

May 14, 2004

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Tosufloxacin tosilate eye drops submitted for Japanese approval

SnET2 NDA accepted for priority review

Proposed financing at InSite to advance AzaSite development

Allergan and Kyorin sign Japanese agreement for Alphagan franchise

FDA sets date to discuss Macugen NDA

Allergan presents new prostaglandin analogues with utility as ocular hypotensive agents

NDA filing for Xibrom

Allergan and Senju sign Japanese licensing agreement for Lumigan

Novel ocular hypotensive agent BVT-28949 effective in monkeys

Pharmacokinetics and efficacy of ranibizumab in exudative AMD

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS